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Aortic valve replacement
Standard:
- mechanical valve prosthesis
- biologic  valve prosthesis ( stentled )                                                                        
- stentless aortic bio-prosthesis
- Homograft   ( mini root, freestyle
aortic root, xenograft )
- Ross procedure
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Ideal aortic valve prosthesis
no resistance to forward flow
low stress gradient
no leak when closed
no damage to blood cells
no thromboembolism
should resist  wear (durability)
should not produce noise                  
easy and simple way of implantation           normal aortic valve 
Cardiosurgery - Skopje
How to do it
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In vitro testing of  the
real stentless aortic valve:
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Real stentless aortic valve new type of aortic root 
reconstructive surgery - in vitro test
These valve parameters had been explored: 1.CO (cardiac output)
2.Root mean square – in dependence of the P, 3.leckage of volume, 
4. elasticity of the leaflets, 5.pressure gradient, 6.resistance of the 
flow
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Real stentless aortic valve new type of aortic root 
reconstructive surgery – in vitro test
Root mean square(EOA) in dependence of CO and systolic pressure 
through the valve ; EOA=RMS/(51,6* p1/2);R=1333* p/MF(mean flow)
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Real stentless aortic valve new type of aortic root 
reconstructive surgery – in vitro test
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Effective orifice area-aorta
 HF SV CO MF RMS P 
 1/min mL L/min mL/s mL/s mmHg 
       
AF04-030403-03 40 20 0,8 53 58 10,7 
22,4°C 40 30 1,2 80 86 14,2 
 70 30 2,1 104 112 17,9 
 100 30 2,9 125 136 22,0 
 40 50 2,0 131 143 23,4 
 70 40 2,8 136 148 24,3 
       
AF04-030403-04 40 20 0,8 53 58 10,5 
37°C 40 30 1,2 80 86 13,8 
 70 30 2,1 103 112 17,9 
 100 30 2,9 126 137 21,6 
 40 50 2,0 132 143 23,2 
 70 40 2,8 137 149 23,9 
 70 49 3,5 169 185 32,7 
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Real stentless aortic valve new type of aortic 
root reconstructive surgery
- our early clinical approaches
 Prospective study N = 115pts with severe aortic stenosis
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I=atherosclerotic ethyology
II=rheumatic ethyology
III=endocarditis
IV=subacute  endocarditis in 
patients on chronic 
haemodyalysis
V = bicupid aortic valve
Cardiosurgery - Skopje
Patients demographics data   N = 115 pts
Age  (years)    56 ± 7.6y    
Sex (f/m)          34 / 81         The oldest patient – 72y
Including criteria:
Severe aortic valve stenosis, with aortic root not bigger than 
3,5cm
Trans-aortic middle pressure gradient >65mmHg
Performed investigations
- Trans-thoracic echocardiography 
- Cathetherisation
- Trans-esophageal echocardiography pre and intra-operatively
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Preoperative co-morbidity          N=115pts
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diabetes
hypercholesterinemia
hypertension
COPD
cerebrovascular disease
subacute endocarditis
haemophylia
%
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Real stentless aortic valve new type of aortic root 
reconstructive surgery 
Post-operative echo
Accepted as a patent in USA 09.12.2008
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Real stentless aortic valve ultrasound 
evaluation bicuspid valve
Pre-op.evaluation Post-op.evaluation
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Results I                        N= 115 pat.
 Middle aorta cross-clamping time           61±9.6min
 Middle bypass time                                  82±12.5min
Intra-operative TEE data
 Dp/dt  = 0.07 0,015; SS= 22±3.2
 EAO cm2=3.6±0,8; CO = 6,5±2.9l
Average systolic valve gradient 14±6.8mmHg
Average mean valve gradient 7±5.6mmHg
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Results  II            N= 115 pts
 Early survival (30 days)           94.8% (8pts)     
 Other main complication:
Bleeding                                    5 pat  (3 surg.ethyology)     
 Ventilation time                        6.8h±2.2         
Stroke                                        2 (1 with left side hemiparesis) 
3pts (with preoperative terminal renal failure) with CVVHD (Prismaflex 
Gambro) 5 days                
 Length of ICU stay                   8.6d ±2.1         
Hospital stay                             14.4 ±3.2      
Patients have been treated with anti-aggregates (Tbl.Aspirin 0,1 1x1)
Simvastatin 
Follow up period                      4-84 months
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Dobutamin stress echo n = 36pts
Protocol:- (5 g/kg/min)dobutamin
-dosage was doubled on every 3 min-up to 12min
-followed parameters: CO,PG syst. and mean through the aortic valve, dp/dt, and 
systolic separation (SS).
0-stadium I-stadium
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Dobutamin stress echo n = 36pts
Remarkable: in all pts CO increased in a linear module with a pressure 
gradient . 56mmHg, was the highest measured systolic pressure gradient in the 
IVth stadium, with a CO 7-9l/min,and dp/dt as in normal valve, with a good SS
IV-stadium recovery
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Proportional ratio of Systolic pressure gradient 
and mean flow rate    n = 36pts
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SPG 24 38 48 56 16
mean flow rate 83 100 110 116 100
3min 6min 9min 12min recovery
Basic parameters
SPG=14 ± 3.5
mean flow 
rate=64 ± 9.5
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Proportional ratio of EAO and CO during 
dobutamin stress echo n = 36pts
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3min 6min 9min 12min recovery
Basic parameters
EOA=3.2 ± 1.5
CO=6.2 ± 2.5
EOA=CO/√sist.
mean 
press.gradient
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Late complications and NYHA class
3 patient re-operated 
1-due to aortic regurgitation bigger 
than +2 as a result of dilatation of 
the aortic annulus
1-due to calcium degeneration of the 
leaflets
1-due to infective endocarditis 
Late mortality  0%.
Follow up 4-84 months
4
33
7
0
8
36
0
5
10
15
20
25
30
35
40
preoperative postoperative
NYHA class IV
NYHA class III
NYHA class II
Cardiosurgery - Skopje
Actuarial survival
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Follow up 4 to 84months
Survival 94,8% -
- early mortality rate 5,2%(8pts)
Pre-op.                                        Post.op.
Real stentless aortic valve ultrasound evaluation aortic inuficienty
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Replacement Aortic Valve  
Leaflets in a patient with a small aortic root  case report
68y.old women
Severe symptomatic aortic 
stenosis
Small aortic root – 16,9mm
Severe calcificated 
ascending aorta up to 
aortic arch
Once deleted operation-
because of her condition
Pre-operative 
echocardiography
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Small-root case report 
operation
6 months follow up 
Excellent haemodinamic
Normal quality of life
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Small-root case report  3D TEE approach
normal aortic valve,perpendicular view
Pre operative
Post operative
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EACTS  2010
Techno-colegue
Award nominee
(printed Daily News)
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